新生血管性青光眼治疗的研究进展

新生血管性青光眼(neovascular glaucoma，NVG)是一种难治性致盲性眼病，给社会增加了沉重负担。NVG的发病与多种因素有关，如视网膜缺血缺氧、炎症及外伤等。可引发其发病的疾病多达40余种，其中临床中最常见的为糖尿病视网膜病变及视网膜中央静脉阻塞等。由于其病因复杂，且发病机制仍不明确，临床治疗存在巨大难度。本文对近年来的一些相关研究进行归纳总结，对NVG的发病及治疗进行阐述，以期望可以对临床工作有所帮助。

Progress in the treatment of neovascular glaucoma

Neovascular glaucoma(NVG)is a refractory blinding eye disease that adds a heavy burden to society. The incidence of neovascular glaucoma is related to a variety of factors, such as retinal ischemia and hypoxia, inflammation and trauma. There are more than 40 diseases that can cause it to occur, among which the most common in clinical is diabetic retinopathy and central retinal vein occlusion. Because of its complex etiology and the pathogenesis remains unclear, clinical treatment is extremely difficult. This paper summarizes some related researches in recent years. Finally, the onset and treatment of neovascular glaucoma are elaborated in order to be expected to help clinical work.